Amsterdam, the Netherlands — 30 October 2020 — LUMICKS is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen receptor (CAR) T-cells using the […]
Company elects luminary as Chairman as they reimagine where Mass Spec technology can be used when it is small in size, low in cost, and simple to operate BOSTON — 908 Devices, a pioneer of purpose-built handheld and desktop Mass Spec devices for chemical and biomolecular analysis, today announced the appointment of Kevin Hrusovsky as the Chairman of […]
By combining two assays in a single platform, the integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc. today announced the launch of a complete Tapestri® Single-cell Multi-omics Solution, the most comprehensive single-cell multi-omics platform on the market. With a new […]
EpiTect Hi-C Kit helps researchers to better understand key aspects of long-range genome architecture License agreement enables QIAGEN to sell Phase Genomics’ proprietary proximity-ligation technology in the United States research market Adds to QIAGEN’s epigenomic capabilities in identification of individual methylation marks and histone modification at the nucleotide level Hilden, Germany, and Germantown, Maryland – QIAGEN […]
Cytiva expanding Massachusetts manufacturing footprint with new facility Hiring approximately 200 people in Massachusetts Responding to growing demand for technologies and solutions Cytiva, a global life sciences leader, will open its new 80,000 square foot manufacturing facility in Shrewsbury, Massachusetts by the end of 2020. Construction is well underway at the new site, which is […]
Agency-wide CRADA agreement also includes studies with Brain-Chip in Alzheimer’s disease, Intestine-Chip in microbiome health, and Liver-Chip in individualized toxicity responses BOSTON, Mass. — Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration (FDA) to enable multiple studies across FDA offices in […]
S2 Genomics, Inc., today announced that it has entered into a distribution agreement with D-Mark Biosciences for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Canada. “Canada is experiencing significant growth in single-cell genomic and cell biology markets, creating a need for […]
MosaicNeedles™, which are novel physical structures, will greatly increase the number of potential protein targets in pharmaceutical companies’ pipelines and usher in a new era of diagnostics BOSTON — NanoMosaic, the pioneer in protein interrogation via proprietary nanoneedles, “MosaicNeedles™,” has announced that on October 15, 2020 it shipped its first Tessie™ Beta System, to a prestigious Boston institution, and validated […]
ABEC providing multiple CSR® single-use systems for new BioInno antibody and gene therapy CDMO facility Bethlehem, PA, USA – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it will be providing CSR single-use mammalian cell culture and microbial fermentation systems, including the industry’s first 6,000L single-use bioreactor, to BioInno Biosciences’ new contract development and […]
– announced at the 2020 American Society of Human Genetics (ASHG) Meeting. Oxford, UK. Oxford Nanopore announces multiple releases that expand and improve its sequencing technology offering in human genomics, at ASHG 2020. These releases are provided without upgrade fees, as with all Oxford Nanopore platforms. They include: a range of data analysis releases, including new basecalling algorithms and downstream analysis tool upgrades. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
